Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Pharma Industry News CVC Capital Partners leads consortium in €3.03bn acquisition of Recordati In a landmark deal valued at approximately €3.03 billion, a consortium led by CVC Capital Partners through its… bySrinathJuly 1, 2018
